NewcelX Ltd. Company Profile
NASDAQ: NCELHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.11+0.075 (+2.47%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
NewcelX at a glance
NewcelX Ltd. (NASDAQ: NCEL) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2021. At a market capitalization of $18.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001783036, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- NewcelX Ltd.
- Ticker
- NASDAQ: NCEL
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Switzerland
- IPO year
- 2021
- Market cap
- $17.96M
- SEC CIK
- 0001783036
Companies similar to NewcelX
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NEUPNeuphoria Therapeutics Inc. | 3.35 | -2.05% | $18.13M | vs NCEL |
| AKTXAkari Therapeutics plc ADS | 8.13 | -5.74% | $18.58M | vs NCEL |
| ACTUActuate Therapeutics Inc. | 0.679 | -6.24% | $16.31M | vs NCEL |
| RADXRadiopharm Theranostics Limited ADR | 1.11 | -3.48% | $16.20M | vs NCEL |
| RKTORocket One Inc. | 0.6461 | -3.57% | $16.09M | vs NCEL |
| PTNPalatin Technologies Inc. | 9.01 | -5.36% | $16.05M | vs NCEL |
| QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares | 3.11 | -1.11% | $20.00M | vs NCEL |
| LPCNLipocine Inc. | 1.93 | -12.27% | $15.91M | vs NCEL |